麻豆传媒

News — Yale Cancer Center (YCC) researchers at Yale School of Medicine will present new research at the in San Diego, Calif., December 7-10.

Known as “the premier event in classical and malignant hematology”, the ASH meeting includes oral and poster presentations, as well as workshops and educational sessions for hematology professionals and advocates. Leading YCC hematologist-oncologists will share advances in treating blood cancers and blood disorders. YCC research will cover treatment disparities among older people with acute myeloid leukemia (AML), screening for psychiatric disorders in sickle cell disease, and the benefits and costs of a targeted antibody treatment for lymphoma. Presentations include:

Saturday, December 7

Presenter:

linical Trial

Presenters: ,

Presenters: , Modupe Karimi, , , ,

Sunday, December 8

Speaker:

Presenter:

Presenter:

Presenters: ,

Monday, December 9

Speaker:

Presenter:

For a full list of YCC presentations at the ASH annual meeting, .

Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center since 1974, Yale Cancer Center is one of only 57 such centers in the nation and the only one in Connecticut. Yale Cancer Center members include national and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.